약물전달 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Drug Delivery Devices Market Growth & Trends:

The global drug delivery devices market size is expected to reach USD 667.4 billion by 2030, registering a CAGR of 7.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

Drug Delivery Devices Market Report Highlights:

• The inhalers segment leads the market with a share of 23.9% in 2024, driven by the demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions.
• The drug delivery devices segment for diabetes dominated the market in 2024 with a share of 21.1%.
• The hospitals segment held the largest market share in 2024 with a share of 29.0%, driven by the rising demand for surgical interventions and preventive procedures.
• The North America drug delivery devices market dominated the overall global market and accounted for the 32.4% revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.21. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing demand for novel drug delivery devices
    • 3.2.1.2. Increasing prevalence of chronic diseases
    • 3.2.1.3. Technological advancement in drug delivery devices
    • 3.2.1.4. Growing strategic alliances for drug delivery devices
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Challenges associated with various routes of drug delivery devices
• 3.3. Drug Delivery Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Drug Delivery Devices Market: Product Movement Analysis
• 4.3. Drug Delivery Devices Market by Product Outlook (USD Billion)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Inhalers
  • 4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.1.1. Metered-dose inhalers (MDIs)
      • 4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.1.2. Dry powder inhalers (DPIs)
      • 4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.1.3. Others
      • 4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.6. Injection Devices
  • 4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.1. Prefilled Syringes
      • 4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.2. Auto-injectors
      • 4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.3. Pen Injectors
      • 4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.4. Needle-free Injectors
      • 4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.1.5. Wearable Injectors
      • 4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.7. Implants
  • 4.7.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.7.1.1. Contraceptive Implants
      • 4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.7.1.2. Drug-eluting Stents
      • 4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.7.1.3. Biodegradable Implants
      • 4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.8. Topical Delivery System
  • 4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.8.1.1. Creams
      • 4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.8.1.2. Gels
      • 4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.8.1.3. Ointments
      • 4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.9. Oral Delivery System
  • 4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.9.1.1. Controlled-release Tablets and Capsules
      • 4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.9.1.2. Buccal and Sublingual Tablets
      • 4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.10. Occular Delivery System
  • 4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.11. Nebulizers
  • 4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.12. Transdermal Patches
  • 4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.13. Infusion Pumps
  • 4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Drug Delivery Devices Market: Application Movement Analysis
• 5.3. Drug Delivery Devices Market by Application Outlook (USD Billion)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Oncology
  • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.6. Infectious Diseases
  • 5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.7. Respiratory Diseases
  • 5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.8. Diabetes
  • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.9. Cardiovascular Diseases
  • 5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.10. Autoimmune Diseases
  • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.11. Central Nervous System Disorders
  • 5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.12. Others
  • 5.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Drug Delivery Devices Market: End-use Movement Analysis
• 6.3. Drug Delivery Devices Market by End-use Outlook (USD Billion)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.6. Diagnostic Centers
  • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.7. Ambulatory Surgery Centers/Clinics
  • 6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.8. Home Care Settings
  • 6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.9. Others
  • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Drug Delivery Devices Market Movement Analysis
• 7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.5. Europe
  • 7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.7. Latin America
  • 7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Gerresheimer AG
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. W. L. Gore & Associates, Inc.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Abbott
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Terumo Medical Corporation
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Stryker
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Medtronic
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Boston Scientific Corporation
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Novartis AG
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Becton, Dickinson and Company
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Teleflex Incorporated
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives